Trial Parameters
Condition Prostate Cancer
Sponsor Profound Medical Inc.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex MALE
Min Age 18 Years
Max Age N/A
Start Date 2021-10-27
Completion 2026-10
All Conditions
Interventions
TULSA Procedure
Brief Summary
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Eligibility Criteria
Inclusion Criteria 1. Male 2. \>18 years old 3. Candidate for TULSA-PRO treatment 4. willing and able to sign the Informed Consent form Exclusion Criteria: None.
Related Trials
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497
View Trial →
NCT07180381
Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy Wit
View Trial →
NCT03650595
MRI Guided Focal Laser Ablation of Prostate Cancer
View Trial →